Page last updated: 2024-08-23

pyoluteorin and Hematologic Malignancies

pyoluteorin has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amin, S; Claxton, D; Doi, K; Dower, C; Gowda, K; Lin, JM; Liu, Q; Loughran, TP; Sung, SS; Wang, HG1

Other Studies

1 other study(ies) available for pyoluteorin and Hematologic Malignancies

ArticleYear
Pyoluteorin derivatives induce Mcl-1 degradation and apoptosis in hematological cancer cells.
    Cancer biology & therapy, 2014, Volume: 15, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Drug Resistance, Neoplasm; Drug Synergism; Female; Hematologic Neoplasms; Humans; Models, Molecular; Molecular Conformation; Myeloid Cell Leukemia Sequence 1 Protein; Phenols; Protein Binding; Protein Interaction Domains and Motifs; Proteolysis; Pyrroles; Stromal Cells; Time Factors; Tumor Burden; Xenograft Model Antitumor Assays

2014